Pharma-Bio Serv (PBSV) Return on Invested Capital (2020 - 2022)

Pharma-Bio Serv (PBSV) posted Return on Invested Capital of 0.02% for Q1 2022, down 33.89% on a QoQ basis from 0.02% in Q4 2021, and down 3.0% year-over-year from 0.02% in Q1 2021.

Pharma-Bio Serv (PBSV) Return on Invested Capital (2020 - 2022) Analysis & Trends

Pharma-Bio Serv's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.02% for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Veeva Systems 33.02 Bn 25.71 Bn 662.02 Mn -
2 Healthequity 8.59 Bn 8.32 Bn 256.31 Mn -
3 10x Genomics 5.96 Bn 5.42 Bn 106.18 Mn -
4 Hinge Health 5.95 Bn 5.64 Bn 154.23 Mn -
5 Waystar Holding 4.58 Bn 4.52 Bn 216.84 Mn 0.05%
6 MiniMed 4.58 Bn 4.28 Bn 480.00 Mn -
7 Doximity 4.00 Bn 3.25 Bn 125.97 Mn -
8 Privia Health 3.07 Bn 2.65 Bn - -
9 Omnicell 1.92 Bn 1.68 Bn 140.36 Mn -
10 Pharma-Bio Serv 13.28 Mn 4.81 Mn 902,041.00 -

Historic Data

Download Data
DateValue
Jan 31, 2022 -0.02%
Oct 31, 2021 -0.02%
Jul 31, 2021 0.00%
Apr 30, 2021 0.00%
Jan 31, 2021 0.01%
Oct 31, 2020 0.01%
Jul 31, 2020 0.02%